
Portfolio Strategy Document
Date: 2024-10-23

Key Initiatives:
1. Focus on repurposing existing molecules
2. Explore diabetes and cardiovascular therapeutic areas
3. Target emerging markets with generic formulations

Strategic Priorities:
- Metformin repurposing for oncology indications
- Atorvastatin lifecycle management
- Partnership opportunities in respiratory space

Next Steps:
- Conduct market analysis for top 10 molecules
- File patents for novel formulations
- Initiate clinical trials for repurposed indications
        